Data-driven sequencing of clinical and biological markers in prodromal stages of inherited prion disease

Vol 1, 2025 - 328529
Abstract Prion 2025
Favorite this paper
How to cite this paper?
Abstract

Characterising sequential biomarker changes against clinical progression in prodromal prion disease can provide insights vital for early diagnosis, and influence design of primary prevention studies. We sought to leverage diverse longitudinal biomarkers and natural history data from the UK National Prion Monitoring Cohort to facilitate individual-level estimates of proximity to clinical disease onset.

 

We followed 27 asymptomatic PRNP mutation carriers annually to clinical onset, with deep clinical profiling, neuropsychological, neurophysiological, and fluid biomarker indices. Carriers were segregated according to mutation-dependent disease durations: very slow (OPRIs), slow (P102L/A117V/T107I) and fast (E200K/D178N). Data were modelled using piecewise linear regression (covariates: age, sex) with time of slope change-points (p < 0.05) reported.

 

Our results identified distinct rates and sequences of changes in clinical and biological markers relative to clinical onset (time 0) for each group – clinical symptoms, neuropsychology and plasma biomarkers between 4-6 years before onset in the very slow group; neurophysiology, clinical symptoms and plasma biomarkers 3-4 years before onset in the slow group; neuropsychology, fluid biomarkers, and clinical symptoms within 1 year before onset in the fast group.

 

Prodromal symptomatology and biomarker trends appear to have a duration mirroring disease duration. Multimodal modelling of biomarker trajectories show promise in stratifying individuals’ proximity to clinical disease onset, crucial for design of, and early recruitment to primary prevention clinical trials.

 

Funding information: the NPMC is funded by the UCLH Trust NIHR Biomedical Research Centre, LHM receives funding from an MRC CRTF

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 MRC Prion Unit at UCL, Institute of Prion Diseases, 33 Cleveland Street, London W1W 7FF, United Kingdom
  • 2 University College London Hospitals NHS Foundation Trust
Track
  • Biomarkers for prion and other prion-like diseases
Keywords
inherited prion disease
prodromal disease
symptomatology
biomarker trajectories
longitudinal